{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:17:27Z","timestamp":1792052247128,"version":"4.4.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>MMF is a mainstay for the treatment of SSc. The occurrence and implications of MMF-related adverse events (AEs) on drug retention rates in real life remain poorly defined. We aimed to determine the MMF retention rate and to investigate the causes and patterns of discontinuation, AEs and treatment options used after discontinuation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>SSc patients who started MMF treatment underwent a retrospective longitudinal assessment for up to 5\u2009years. We documented the incidence, predictors and impacts of MMF treatment on gastrointestinal intolerance, infections, laboratory abnormalities and cancer. Rescue strategies implemented after MMF discontinuation were recorded.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The 5-year MMF retention rate of 554 patients stood at 70.7%, and 19.6% of them stopped MMF due to AEs. One out of every four patients experienced a dose reduction or discontinuation of MMF due to AEs, with gastrointestinal intolerance being the predominant cause. The 5-year cumulative incidence rates for gastrointestinal intolerance, cancer, severe infections and laboratory toxicity leading to MMF discontinuation were 6.4%, 4.1%, 3.1% and 2.1%, respectively. Lower respiratory tract was the most affected, with bacteria being the predominant causative agent. Intestinal and pulmonary circulation involvement were tied to elevated AE rates and MMF discontinuation. The most common approaches post-MMF cessation were \u2018watch and wait\u2019 and switch to rituximab.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>: MMF use in SSc appears to be limited by the occurrence of AEs, both in terms of persistence and dosing of the drug. Rescue options after MMF discontinuation are limited and many patients remain without immunosuppressant.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae532","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T15:49:29Z","timestamp":1727711369000},"page":"1966-1974","source":"Crossref","is-referenced-by-count":4,"title":["Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9819-105X","authenticated-orcid":false,"given":"Enrico","family":"De Lorenzis","sequence":"first","affiliation":[{"name":"Unit of Rheumatology, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome,","place":["Italy"]},{"name":"Scleroderma Program, Leeds Institute of Rheumatic and Musculoskeletal Diseases, University of Leeds , Leeds,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerlando","family":"Natalello","sequence":"additional","affiliation":[{"name":"Unit of Rheumatology, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Pellegrino","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome , Rome,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucrezia","family":"Verardi","sequence":"additional","affiliation":[{"name":"Unit of Rheumatology, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Batani","sequence":"additional","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital , Milan,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Lepri","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Florence , Florence,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Stano","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Emergency and Organs Transplantation, Universit\u00e0 degli Studi di Bari Aldo Moro , Bari,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Armentano","sequence":"additional","affiliation":[{"name":"Scleroderma Clinic, Dip. Reumatologia, ASST G. Pini-CTO, Universit\u00e0 degli Studi di Milano , Milano,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0947-8663","authenticated-orcid":false,"given":"Marco","family":"De Pinto","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of Modena and Reggio Emilia , Modena,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Motta","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital , Rozzano,","place":["Italy"]},{"name":"Department of Biomedical Sciences, Humanitas University , Pieve Emanuele,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Di Donato","sequence":"additional","affiliation":[{"name":"Scleroderma Program, Leeds Institute of Rheumatic and Musculoskeletal Diseases, University of Leeds , Leeds,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Kakkar","sequence":"additional","affiliation":[{"name":"Scleroderma Program, Leeds Institute of Rheumatic and Musculoskeletal Diseases, University of Leeds , Leeds,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Fiore","sequence":"additional","affiliation":[{"name":"Unit of Rheumatology, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Bisconti","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome , Rome,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6806-3794","authenticated-orcid":false,"given":"Corrado","family":"Campochiaro","sequence":"additional","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital , Milan,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cometi","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Florence , Florence,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Tonutti","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital , Rozzano,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Spinella","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of Modena and Reggio Emilia , Modena,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Truglia","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome , Rome,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Cavalli","sequence":"additional","affiliation":[{"name":"Scleroderma Clinic, Dip. Reumatologia, ASST G. Pini-CTO, Universit\u00e0 degli Studi di Milano , Milano,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3196-1336","authenticated-orcid":false,"given":"Maria","family":"De Santis","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital , Rozzano,","place":["Italy"]},{"name":"Department of Biomedical Sciences, Humanitas University , Pieve Emanuele,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0041-3695","authenticated-orcid":false,"given":"Dilia","family":"Giuggioli","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University of Modena and Reggio Emilia , Modena,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1549-8852","authenticated-orcid":false,"given":"Nicoletta","family":"Del Papa","sequence":"additional","affiliation":[{"name":"Scleroderma Clinic, Dip. Reumatologia, ASST G. Pini-CTO, Universit\u00e0 degli Studi di Milano , Milano,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Guiducci","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Florence , Florence,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7479-4462","authenticated-orcid":false,"given":"Fabio","family":"Cacciapaglia","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Emergency and Organs Transplantation, Universit\u00e0 degli Studi di Bari Aldo Moro , Bari,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5306-7714","authenticated-orcid":false,"given":"Giacomo","family":"De Luca","sequence":"additional","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital , Milan,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0474-5344","authenticated-orcid":false,"given":"Fiorenzo","family":"Iannone","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Emergency and Organs Transplantation, Universit\u00e0 degli Studi di Bari Aldo Moro , Bari,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Ricceri","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome , Rome,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Matucci Cerinic","sequence":"additional","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital , Milan,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"D\u2019Agostino","sequence":"additional","affiliation":[{"name":"Unit of Rheumatology, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8528-2283","authenticated-orcid":false,"given":"Francesco","family":"Del Galdo","sequence":"additional","affiliation":[{"name":"Scleroderma Program, Leeds Institute of Rheumatic and Musculoskeletal Diseases, University of Leeds , Leeds,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Laura","family":"Bosello","sequence":"additional","affiliation":[{"name":"Unit of Rheumatology, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS , Rome,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"2025040212143346400_keae532-B1","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2025040212143346400_keae532-B2","doi-asserted-by":"crossref","first-page":"e0124205","DOI":"10.1371\/journal.pone.0124205","article-title":"Safety and effectiveness of mycophenolate in systemic sclerosis. A systematic review","volume":"10","author":"Omair","year":"2015","journal-title":"PLoS One"},{"key":"2025040212143346400_keae532-B3","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"key":"2025040212143346400_keae532-B4","doi-asserted-by":"crossref","first-page":"2202071","DOI":"10.1183\/13993003.02071-2022","article-title":"Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial","volume":"61","author":"Mankikian","year":"2023","journal-title":"Eur Respir J"},{"key":"2025040212143346400_keae532-B5","first-page":"62","article-title":"Infections and systemic sclerosis: an emerging challenge","volume":"27","author":"Barahona-Correa","year":"2020","journal-title":"Rev Colomb Reumatol"},{"key":"2025040212143346400_keae532-B6","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/14397595.2014.980384","article-title":"Pulmonary infections following immunosuppressive treatments during hospitalization worsen the short-term vital prognosis for patients with connective tissue disease-associated interstitial pneumonia","volume":"25","author":"Tanaka","year":"2015","journal-title":"Mod Rheumatol"},{"key":"2025040212143346400_keae532-B7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/bcp.14979","article-title":"Mycophenolic acid and cancer risk in solid organ transplant recipients: systematic review and meta-analysis","volume":"88","author":"Hirunsatitpron","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"2025040212143346400_keae532-B8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12016-023-08963-3","article-title":"Perspectives on mycophenolate mofetil in the management of autoimmunity","volume":"65","author":"Bhat","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"2025040212143346400_keae532-B9","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"Von Elm","year":"2007","journal-title":"BMJ"},{"key":"2025040212143346400_keae532-B10","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"Van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2025040212143346400_keae532-B11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3352\/jeehp.2013.10.12","article-title":"The retrospective chart review: important methodological considerations","volume":"10","author":"Vassar","year":"2013","journal-title":"J Educ Eval Health Prof"},{"key":"2025040212143346400_keae532-B12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.tp.0000225762.54757.f7","article-title":"A grading system based on severity of infection to predict mortality in allogeneic stem cell transplant recipients","volume":"82","author":"Cordonnier","year":"2006","journal-title":"Transplantation"},{"key":"2025040212143346400_keae532-B13","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1002\/sim.7501","article-title":"Practical recommendations for reporting Fine-Gray model analyses for competing risk data","volume":"36","author":"Austin","year":"2017","journal-title":"Stat Med"},{"key":"2025040212143346400_keae532-B14","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1002\/sim.1915","article-title":"Sample size formula for proportional hazards modelling of competing risks","volume":"23","author":"Latouche","year":"2004","journal-title":"Stat Med"},{"key":"2025040212143346400_keae532-B15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"2025040212143346400_keae532-B16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/2397198320944342","article-title":"Mycophenolic acid drug monitoring in patients with systemic sclerosis associated with diffuse skin and\/or pulmonary involvement: a monocentric and retrospective French study","volume":"6","author":"Legendre","year":"2021","journal-title":"J Scleroderma Relat Disord"},{"key":"2025040212143346400_keae532-B17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0012-3692(15)50949-5","article-title":"Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease","volume":"130","author":"Swigris","year":"2006","journal-title":"Chest"},{"key":"2025040212143346400_keae532-B18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/23971983211024410","article-title":"Mycophenolate in scleroderma-associated interstitial lung disease: real-world data from rheumatology and pulmonology clinics in South Asia","volume":"6","author":"Janardana","year":"2021","journal-title":"J Scleroderma Relat Disord"},{"key":"2025040212143346400_keae532-B19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.ftd.0000199358.80013.bd","article-title":"Therapeutic drug monitoring of mycophenolate mofetil in transplantation","volume":"28","author":"Van Gelder","year":"2006","journal-title":"Ther Drug Monit"},{"key":"2025040212143346400_keae532-B20","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/art.27495","article-title":"Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil","volume":"62","author":"Zahr","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2025040212143346400_keae532-B21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/cei.12246","article-title":"Mycophenolate mofetil in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis: a prospective pharmacokinetics and clinical study","volume":"176","author":"Chaigne","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"2025040212143346400_keae532-B22","first-page":"keae280","article-title":"Rituximab retention rate in systemic sclerosis: a long term real-life multicenter study","volume":"15","author":"De Luca","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2025040212143346400_keae532-B23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13075-020-02323-8","article-title":"Mycophenolate mofetil for systemic sclerosis: drug exposure exhibits considerable inter-individual variation-a prospective, observational study","volume":"22","author":"Andr\u00e9asson","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2025040212143346400_keae532-B24","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.semarthrit.2020.08.004","article-title":"Rituximab as a rescue treatment added on mycophenolate mofetil background therapy in progressive systemic sclerosis associated interstitial lung disease unresponsive to conventional immunosuppression","volume":"50","author":"Narv\u00e1ez","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2025040212143346400_keae532-B25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S2213-2600(20)30330-1","article-title":"Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial","volume":"9","author":"Highland","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2025040212143346400_keae532-B26","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3899\/jrheum.111229","article-title":"A prospective observational study of mycophenolate mofetil treatment in progressive diffuse cutaneous systemic sclerosis of recent onset","volume":"39","author":"Mendoza","year":"2012","journal-title":"J Rheumatol"},{"key":"2025040212143346400_keae532-B27","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/rheumatology\/kel244","article-title":"Mycophenolate mofetil in diffuse cutaneous systemic sclerosis\u2014a retrospective analysis","volume":"46","author":"Nihtyanova","year":"2007","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae532\/59729768\/keae532.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/1966\/59729768\/keae532.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/4\/1966\/59729768\/keae532.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T18:44:44Z","timestamp":1743619484000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/4\/1966\/7796566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,9,30]]},"published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae532","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,9,30]]}}}